A recent WebMD article discussed a nationwide thyroid drug recall linked to incorrect information on the label. The drug in question is Acella Pharmaceuticals’ NP Thyroid medication intended to treat hypothyroidism. During routine testing, the affected lots were found to contain less than 90% of the two ingredients listed on the label: liothyronine and levothyroxine.
Incorrect Label Potency Leads to Thyroid Drug Recall
Acella Pharmaceuticals has recalled its thyroid medication for the third time in a year over potency issues.
May 14, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More